What You Should Know:
– CorroHealth, a leading provider of revenue cycle management (RCM) solutions to health systems and health plans, announced it has signed definitive agreements for a strategic investment from Patient Square Capital (Patient Square), a dedicated health care investment firm.
– Current shareholders, including investment funds affiliated with global investment firm Carlyle (NASDAQ: CG), TT Capital Partners, Sanaka Group, and CorroHealth management, will remain investors, with Patient Square and Carlyle sharing joint control of CorroHealth.
CorroHealth: Driving Healthcare Financial Performance through Clinically Led Analytics and Technology Solutions
CorroHealth is a global leader in healthcare analytics and technology-driven solutions, committed to enhancing financial performance for physicians, hospitals, and health plans. With a team of over 15,000 employees across 10 locations worldwide—including the United States, India, and the United Kingdom—CorroHealth delivers integrated solutions powered by intelligent technology and proven expertise, providing scalability across the entire revenue cycle.
Backed by Carlyle since 2019, with initial investments in predecessor businesses dating to 2017, CorroHealth has evolved into a robust, clinically driven revenue cycle management (RCM) platform. “Since its inception in 2019, CorroHealth has grown into a technology and clinically led healthcare RCM platform,” said CEO Pat Leonard. “We are pleased to welcome the Patient Square team, whose extensive experience in scaling healthcare companies aligns with our goals to expand our capabilities and deliver exceptional value to our customers.”
This strategic partnership leverages CorroHealth’s commitment to innovation, supporting its mission to create impactful financial solutions for healthcare organizations worldwide.
